Dr. Xiaojing Du 杜晓京
Chief Physician
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for central nervous system tumors, head and neck tumors, and nasopharyngeal carcinoma.
Name order: in Chinese the family name comes first (Du Xiaojing). Papers usually list the name as Xiaojing Du or Du X.
Selected publications
50 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Med, 2026 (senior author): Defining optimal treatment strategies for nasopharyngeal carcinoma based on the ninth edition TNM staging system: insights from a multicenter cohort study in an endemic region. PubMed 42897534
- Cell Rep Med, 2025 (senior author): Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinoma. PubMed 39938522
- BMC Cancer, 2024 (senior author): In-depth exploration of the focus issues of TKI combined with radiotherapy for EGFR-mutant lung adenocarcinoma patients with brain metastasis: a systematic analysis based on literature metrology, meta-analysis, and real-world observational data. PubMed 39443874
- Cancer Cell, 2024 (first author): Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma. PubMed 38242125
- J Cancer, 2019 (first author): Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial. PubMed 31289592
- Front Oncol, 2018 (first author): Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients. PubMed 30619745
- Head Neck, 2017 (first author): Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma. PubMed 27997061
- J Cancer, 2016 (first author): Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma. PubMed 27076847
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion